PRFX (PRF Technologies) 3-Year Share Buyback Ratio: -352.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PRFX PRF Technologies Ltd PRFX
22 GF Score
Price $0.93
! 1 Warning Sign
View Full Analysis

What is PRF Technologies 3-Year Share Buyback Ratio?

PRF Technologies PRFX -2.38% 22 3-Year Share Buyback Ratio is -352.00 as of Jun. 2026. GuruFocus rates PRFX with a GF Score™ of 22/100. The stock has 1 warning sign investors should review. Among 645 Drug Manufacturers companies, PRF Technologies ranks worse than 99.07% on this metric.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. PRF Technologies's current 3-Year Share Buyback Ratio was -352.00%.

The historical rank and industry rank for PRF Technologies's 3-Year Share Buyback Ratio or its related term are showing as below:

PRFX' s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -352   Med: -26   Max: -8.7
Current: -352

During the past 8 years, PRF Technologies's highest 3-Year Share Buyback Ratio was -8.70%. The lowest was -352.00%. And the median was -26.00%.

PRFX's 3-Year Share Buyback Ratio is ranked worse than
99.07% of 645 companies
in the Drug Manufacturers industry
Industry Median: -2.1 vs PRFX: -352.00

PRF Technologies (NAS:PRFX) 3-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.


Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.


PRF Technologies 3-Year Share Buyback Ratio Related Terms


PRFX vs CTTH, UPC, AKAN: 3-Year Share Buyback Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PRF Technologies's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PRF Technologies 3-Year Share Buyback Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PRF Technologies's 3-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where PRF Technologies's 3-Year Share Buyback Ratio falls into.


PRFX
22GF Score
PRF Technologies Ltd PRFX
3-Year Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PRF Technologies 3-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

What does a 3-Year Share Buyback Ratio of -352.00 mean?
PRF Technologies (PRFX) has a 3-Year Share Buyback Ratio of -352.00 as of Jun. 2026. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for PRF Technologies and its competitors. According to the industry distribution chart, PRF Technologies ranks #639 out of 645 companies in the Drug Manufacturers industry, placing it in the top 99.1%.
Is PRF Technologies' 3-Year Share Buyback Ratio too high?
PRF Technologies' current 3-Year Share Buyback Ratio is -352.00. Based on the distribution chart, PRF Technologies ranks #639 out of 645 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, PRF Technologies has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does PRF Technologies' 3-Year Share Buyback Ratio compare to CTTH and UPC?
According to the Drug Manufacturers industry distribution chart, PRF Technologies ranks #639 out of 645 companies for 3-Year Share Buyback Ratio. This places PRF Technologies in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for a Drug Manufacturers company?
A good 3-Year Share Buyback Ratio depends on the Drug Manufacturers industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for PRF Technologies and its competitors. PRF Technologies's current 3-Year Share Buyback Ratio is -352.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PRF Technologies stock overvalued right now?
PRF Technologies (PRFX) has a current 3-Year Share Buyback Ratio of -352.00. The current 3-Year Share Buyback Ratio is -352.00. PRF Technologies' overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For PRF Technologies (PRFX), the current 3-Year Share Buyback Ratio is -352.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PRF Technologies Business Description

Address 65 Yigal Alon Street, Tel Aviv, ISR, 6744316
PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasize reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the company's lead product, is based on the local anesthetic ropivacaine and targets the postoperative pain relief market. The company has two operating segments composed of the Clinical Development segment, which facilitates the development of potential new drug compounds, and the Solar segment, which comprises the design and development of the company's intellectual property and the sale related service offerings.
22GF Score

Get the complete analysis for PRFX

3-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.93
Price